TikTok Content Creators Driving Parallel Market for Unlicensed Slimming Medication

A shadow economy for unapproved slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.

Experimental Treatment Gaining Popularity Online

Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its alleged fat-burning effects. Followers are urged to message these accounts directly for supplier links, while also obtaining promotional offers.

Thriving Commerce on Messaging Platforms

Additionally, a flourishing trade exists on Telegram, where groups with thousands of members share “before and after” photos, administration instructions and assertions of rapid UK delivery. Sellers promote the substance there before directing buyers to other platforms for purchases.

Understanding The Experimental Drug

This medication is an investigational injectable created by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could help patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Medical Professionals Express Worries

Nevertheless, physicians and chemists have warned that the distribution of what is still an unapproved drug in the UK is worrisome and could result in users injecting substances of unknown origin.

Several experts stated the popularity for retatrutide could be connected to the increasing cost of approved weight loss products such as Mounjaro.

Regulatory Position and Enforcement

Marketing the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that cannot be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Some content creators try to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still breach pharmaceutical, marketing, and customer laws, potentially leading to fines, legal action or prison.

Service Reaction and Content Elimination

According to TikTok, the platform has taken down problematic material and banned associated keywords and search suggestions. The organization stated it was committed to keeping the service secure and investing in enhancing enforcement strategies.

Digital Trading Operations

Research also found groups with up to 9,000 members marketing the experimental drug using the platform's integrated discovery tool, which functions like a public directory. Entering “retatrutide” immediately brings up channels with numerous of members, filled with images of slimming results, positive testimonials and detailed instructions for mixing or administering at residence.

Within moments of joining one community, a seller shared WhatsApp details, where the majority of transactions occur. The vendor provided an guidebook and promised delivery within two days. When asked whether the substance was authentic, one vendor responded: “You can’t be sure.” Another shared a image of a alleged testing documentation. None inquired about body mass, health issues or past usage.

Item Details and Pricing

Inside these communities, posts show dark colored parcels with Royal Mail stickers, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at home with sterile water, or pre-filled pens typically sold at £160 for 20 milligrams. When questioned how long a pen should be used, sellers give conflicting answers ranging from a several days to “depends on your body”.

Service Moderation and Safety Measures

A spokesperson for Telegram stated it actively moderated dangerous content on its platform including content that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are administering substances they can’t verify. Even if the research behind retatrutide is sound, these online products may not include what they claim,” stated a pharmacy expert, the head of pharmacy at Chemist4U.

A medical professional of an online medical service linked the increase in interest to recent price rises for authorized slimming medications such as Mounjaro. “With prices increasing, patients are turning to social media. But counterfeit injections are highly risky. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she said.

Her team has previously encountered individuals harmed by self-injection from unconfirmed suppliers. “We understand the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your health,” stated the doctor. “These substances could be impure or incorrectly dosed.”

Producer Position

A representative from the pharmaceutical company stated the substance was in phase 3 research studies and had not been reviewed or approved by any government authority anywhere in the world. “Consequently at this point no one can market [it] for personal consumption,” they said, noting that any product “falsely representing itself as a company investigational substance not yet approved … may expose users to possibly serious medical dangers”.

Christine Jensen
Christine Jensen

Eleanor is a freelance journalist and culture critic based in London, covering art, design, and independent creators across the UK.